{"disease":{"id":"anti-nmda-n-methyl-d-aspartate-receptor-encephalitis","name":"anti nmda n methyl d aspartate receptor encephalitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06023160","title":"Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":714,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07093333","title":"A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Arialys Australia Pty Ltd","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}